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Gregory L. Moneta, MD, Section EditorEvidence for a Strong Genetic Inﬂuence on Carotid Plaque
Characteristics: An International Twin Study
Tarnoki AD, Baracchini C, Tarnoki DL, et al. Stroke 2012;43:3168-72.
Conclusion: Heritability of ultrasound plaque characteristics is high.
Summary: Only a few studies have even partially investigated genetic
determinants of carotid plaque characteristics. The San Antonio Family
Heart Study found moderate (23%-28%) heritability of the presence of
carotid plaques (Hunt KJ et al, Stroke 2002;33:2775-80). The Erasmus
Rucphen Family (ERF) study used a carotid plaque score to quantify
common carotid artery carotid bifurcation and internal carotid artery plaque
and found 28% heritability of the carotid plaque (Sayed-Tabatabaei FA et al,
Stroke 2005;36:2351-6). It is also known that underlying atherosclerotic
phenotypes associated with carotid plaque formation (intima-media thick-
ness, arterial stiffness) can also exhibit moderate heritability. However,
genetic determinants related directly to carotid plaque characteristics are
not clear. The authors sought to study the heritability of carotid plaque
characteristics in a twin population. Twin studies more reliably estimate rela-
tive contribution of genes to phenotypic traits than can be determined with
a “family study” design. There were 192 monozygotic and 83 dizygotic
adult twin pairs (age 49 6 15 years) from Italy, Hungary, and the United
States who underwent B-mode and color Doppler ultrasound imaging of
their bilateral common, internal, and external carotid arteries. Age-, sex-,
and country-adjusted heritability was 78% for the presence of carotid plaque
(95% conﬁdence interval [CI] 55%-90%), 74% for plaque echogenicity (95%
CI, 38%-87%), and 69% for plaque size (area in mm2 in longitudinal plane;
<50 percentile or >50 percentile; 95% CI, 16%-86%). Adjusted heritability
for plaque sidedness was 74% (95% CI, 25%-90%). Heritability was 74% for
plaque numerosity (95% CI, 26%-86%) and 68% (95% CI, 40%-84%) and
66% (95% CI, 32%-90%), respectively, for presence of plaque in the carotid
bulb and proximal internal carotid artery. No role for shared environmental
factors was found. The remaining variants (22%-34%) were attributed to
unique environmental factors. Controlling for relative covariates did not
change the results of the study signiﬁcantly.
Comment: This is the ﬁrst international twin population study to
investigate heritability of carotid plaque characteristics. Heritability of the
carotid plaque in this study is considerably higher than in previous studies,
with the inevitable corollary that the inﬂuence of unique environmental
factors on development of carotid plaque is actually moderate. Because
unshared environmental factors accounted for only a modest portion of vari-
ability in carotid plaque, the authors’ ﬁndings should stimulate a search for
genes responsible for the variability of carotid plaque in response to athero-
sclerotic risk factors.Current Prevalence of Abdominal Aortic Aneurysm in 70-Year-Old
Women
Svensjo S, Bjorck M, Wanhainen A. Br J Surg 2013;100:367-72.
Conclusion: Screening 70-year-old women who do not smoke is
likely to be ineffective in discovering abdominal aortic aneurysm (AAA).
Summary: Ultrasound screening of older men for AAA is an
evidence-based method to reduce aneurysm-related and all-cause mortality.
The only randomized study including women, however, demonstrated no
reduction in mortality with aortic aneurysm screening (Scott RA et al, Br
J Surg 2005;89:283-5). A modeling study, however, suggests screening
woman could be cost-effective given the observed higher rupture rates of
AAA in women and increased longevity among women compared with
men (Wanhainen A et al, J Vasc Surg 2006;43:908-14). The Society for
Vascular Surgery recommends aneurysm screening among older women
with a family history of AAA or who have smoked (Chaikof EL et al.
J Vasc Surg 2009;50(Suppl):S2-49). The U.S. Preventative Services Task
Force, however, found no evidence of beneﬁt in screening women, regard-
less of risk factors (U.S. Preventative Task Force, Ann Intern Med
2005;142:198-202). However, people also may be healthier now, and
with delayed aneurysm development, than at the time screening for AAAs
was ﬁrst evaluated. The aim of this study was therefore to determine the
prevalence of AAA and risk factors in a contemporary well-deﬁned popula-
tion of 70-year-old women. The study targeted 70-year-old women because
previous investigations suggested AAAs present later in life in women thanin men (Katz DJ et al, J Vasc Surg 1997;25:561-8). The 70-year-old
women were identiﬁed through the Swedish National Population Registry
in two neighboring counties of Uppsala and Dalarna and were invited to
a free ultrasound examination of the abdominal aorta. An aorta >30 mm
in diameter was deﬁned as an AAA. Of the 6925 women who were invited,
5140 (74.2%) accepted the invitation for screening and 19 AAAs (0.4%)
were detected (95% conﬁdence interval [CI], 0.2%-0.5%). In the invited
cohort, 12 women (0.2%; 95% CI, 0.1%-0.3%) had undergone previous
AAA repair (11) or had a known AAA under surveillance (one). The total
prevalence of AAA was therefore estimated at 0.5% (0.4%-0.7%). Of 19
women with screen-detected AAAs, 18 (95%) had a history of smoking
compared with a smoking history of 44.2% of those with a normal aorta
(odds ratio, 20.29; 95% CI, 2.7-152.65). Prevalence of AAA was 0.03%
(0%-0.1%) among never smokers, 0.4% (0.2%-0.8%) among former smokers,
and 2.1% (1.0%-3.7%) among current smokers.
Comment: People are getting healthier and engaging in less risky
behavior. In the current study, smoking was the only independent risk factor
for AAA. Previous studies have indicated higher rates among women for
smoking history, hypertension, elevated cholesterol, and coronary disease
than were found in the current study (Derubertis BG et al, J Vasc Surg
2007;46:630-7 and Lederle FA et al, J Vasc Surg 2001;34:122-6). In
Sweden, a 70-year-old woman is likely to live another 17 years. We also
know that at least in men, some people who initially screen negatively will
eventually die of a ruptured AAA. Therefore, although the data certainly
indicate screening for AAA among nonsmoking woman at age 70 is of no
beneﬁt, the value of targeted screening of an older woman who is still
smoking is potentially an open question. Given the low prevalence of aneu-
rysm in women, this question is unlikely to be answered without a study
randomizing at least 100,000 elderly women; a study so ponderous as to
be a logistic impossibility.Final Follow-up of the Multicentre Aneurysm Screening Study
(MASS) Randomized Trial of Abdominal Aortic Aneurysm Screening
Thompson SG, Ashton HA, Gao L, et al, on behalf of the Multicentre
Aneurysm Screening Study (MASS) Group. Br J Surg 2012;99:1649-56.
Conclusion: Screening for abdominal aortic aneurysms (AAA) results
in a reduction of all-cause mortality out to 13 years of follow-up.
Summary: The UK Multicenter Aneurysm Screening Study (MASS)
is the largest randomized trial of screening vs no screening of AAAs to
reduce aneurysm and all-cause mortality. Previous results from MASS
were published after 10 years of follow-up (Thompson SG et al, BMJ
2009;338;b2307). At that time, there was some increase in rupture of
AAA among those initially screened as normal. However, this increase
had no impact on overall proportionate AAA-related mortality. The 15-
year results of the UK Chichester trial suggested a possible substantial
increase in ruptured AAAs during follow-up (Ashton HA et al, Br J Surg
2007;94:696-701). Signiﬁcant numbers of AAA ruptures in those initially
screened as normal could result in a long-term reduction of beneﬁts in
AAA mortality implied by a normal initial screening study. This latest publi-
cation from the MASS trial investigators examined further follow-up in the
MASS trial participants with respect to potential beneﬁts of all-cause
mortality and late AAA rupture in those initially screened as normal. The
MASS trial was a population-based sample of men aged 65 to 74 years
who were randomized to an invitation for ultrasound screening (invited
group) for AAA or to a control group that was not offered screening.
Patients with an abdominal aorta >3 cm detected at the initial study under-
went surveillance and were offered surgery after predeﬁned criteria had been
met. Cause-speciﬁc mortality data were analyzed using Cox regression tech-
niques. The study enrolled 67,770 men. Over 13 years, 224 AAA-related
deaths occurred in the invited group and 381 in the control group. This
was a relative risk reduction of 42% in the invited group compared with
the control group (hazard ratio, 0.58; 95% conﬁdence interval, 0.49-
0.69). Relative risk reduction did not vary by baseline age or center, and
there was no evidence of an effect on other causes of death. There was an
overall reduction in all-cause mortality of 3% (1%-5%). Beneﬁt was greater
in earlier years of follow-up and decreased with longer follow-up, with
a risk reduction of 48% from randomization to 10 years and 20% from 10
to 14 years. During the 13-year interval, nonfatal AAA ruptures were halved1447
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After a normal ﬁrst scan, 59 ruptured AAAs occurred, and 80% of these
were fatal. Ruptured AAA after a normal ﬁrst scan had a marked increase after
8 years of follow-up. Among the measured baseline aortic diameters, about
half of those initially screened as normal and subsequently having ruptured
AAA were in the initial screening range of aortic diameters of 2.5 to 2.9 cm.
Comment: There are at least two ﬁndings that should be emphasized
here. The ﬁrst is that screening for AAA reduces all-cause mortality. The
second is that screening is not perfect, and some patients will still develop
aneurysms and die from them after an initial so-called negative screening
study. The MASS trial measured AAAs with inner-to-inner wall measure-
ments of diameter by ultrasound imaging. Theoretically, because this results
in a smaller diameter measurement, use of the Society for Vascular Surgery
guidelines for measuring abdominal aortas from outer-to-outer wall could
potentially save some ruptures without rescreening of “normals” or an
increase in the number of initial screening studies.Causes and Implications of Readmission After Abdominal Aortic
Aneurysm Repair
Greenblatt DY, Greenburg CC, Kind A, et al. Ann Surg 2012;256:595-605.
Conclusion: Early readmission is common after abdominal aortic
aneurysm (AAA) repair.
Summary: Almost one in ﬁve hospitalized Medicare patients are read-
mitted #30 days of discharge. The costs are enormous, >$17.4 billion per
year (Jencks SF et al, N Engl J Med 2009;360:1418-28). In addition,
vascular surgical procedures are among the most common procedures
leading to readmission, with Medicare readmission rates for vascular patients
approaching 24%. The Medicare Payment Advisory Commission has identi-
ﬁed vascular procedures as one of seven categories that are particularly likely
to lead to preventable readmissions. On a per-patient basis, vascular surgery-
related readmissions are also the most costly (Hackbarth G et al, Report to
the Congress: Promoting Greater Efﬁciently in Medicare. Memphis, TN:
Books LLC; 2007). Vascular procedures are set to be added to the Center
for Medicare and Medicaid Services (CMS) tracking of hospital risk-
adjusted 30-day readmission rates for selected medical conditions. Because
CMS is set to reduce Medicare reimbursements to hospitals with higher-
than-predicted readmission rates, it is important to systematically study
vascular surgery-speciﬁc readmissions. In this study, the authors described
the frequency, causes, predictors, and consequences of 30-day readmission
after AAA repair in a Medicare population. Elective AAA repairs over a 2-
year period from the CMS chronic conditions warehouse, a 5% national
sample of Medicare beneﬁciaries, were studied. There were 2481 patients
who underwent AAA repair, comprising 1502 endovascular aneurysm
repairs (EVAR) and 749 open aneurysm repairs. The 30-day readmission
rates were equivalent for EVAR (13.3%) and open repair (12.8%). Wound
complication was the most common reason for readmission after both
procedures. The relative frequency of other causes differed (ie, bowel
obstruction after open repair and graft complication after EVAR). A multi-
variate analysis showed preoperative comorbidities had a modest effect on
readmission. However, postoperative factors, including serious complica-
tions leading to a prolonged hospital stay and a discharge destination other
than home, had a profound inﬂuence on the probability of readmission. The
1-year mortality was 23.4% in readmitted patients vs 4.5% in those not read-
mitted (P < .001). In-hospital mortality for patients readmitted from
a skilled nursing facility was 9.8%.
Comment: With the looming advent of Medicare payment conse-
quences for hospital readmissions, the study of hospital readmissions has
become a hot topic. Just when we have all grown use to the emphasis of
limiting inpatient stays, we must now adjust to the reality that inpatient stays
may need to be extended to avoid hospital readmission! It really boils down
to the fact the only way to deal with all of this is to do a better job of select-
ing our patients for surgery, perform our procedures better, and be aware of
risk factors that may prompt a prolonged recovery or hospital readmission.
Hopefully, this will not result in denial of care to patients who could beneﬁt
from aneurysm repair.21st-Century Hazards of Smoking and Beneﬁts of Cessation in the
United States
Jha P, Ramasundarahettige C, Landsman V, et al. N Engl J Med
2013;368:341-50.
Conclusion: Compared with those who have never smoked, smokers
lose at least one decade of life expectancy. If smokers quit before the age of
40 years, this reduces the risk of death associated with continued smoking
by w90%.
Summary: Extrapolation of data from the 1980s suggest that for
those aged between 35 and 69 years, smoking will contribute to almost200,000 deaths annually in the United States, about one-fourth of all deaths
in these aged 35 to 69 years (Department of Health and Human Services.
The health consequences of smoking; a report of the Surgeon General.
Washington, D.C.; Government Printing Ofﬁce, 2004). In high-income
countries, there are now more former smokers than current smokers.
However, the cessation of smoking is uncommon in low-income and
middle-income countries (Jha P, Nat Rev Cancer 2009;9:655-64). Data
indicate that on the basis of current rates of smoking initiation and cessation,
smoking has killed w100 million people in the 20th century and will kill
w1 billion people in the 21st century (Peto R et al, http://www.ctsu.ox.
ac.uk/wtobacco). In this study, the authors used data from the U.S.
National Health Interview Survey to obtain smoking and smoking-cessation
histories from 113,752 women and 88,496 men who were aged $25 years
between 1997 and 2004. Data were then related to causes of death that
occurred by December 31, 2006. In this period, there were 8236 deaths
in the women and 7479 deaths in the men initially interviewed. Hazard
ratios for death among current smokers compared with those who had never
smoked were adjusted for age, education level, adiposity, and alcohol
consumption. Participants aged between 25 and 79 years had a death rate
from any cause among current smokers that was about three times that
among those who had never smoked (hazard ratio for women, 3.0; 99%
conﬁdence interval, 2.7-3.3; hazard ratio for men, 2.8; 99% conﬁdence
interval, 2.4-3.1). Neoplastic, vascular, respiratory, and other diseases
caused by smoking accounted for most of the excess mortality among
smokers. The probability of surviving from 25 to 79 years of age was about
twice as great in those who had never smoked as in current smokers (70% vs
38% for women and 61% vs 26% for men). There was w10 years less life
expectancy among current smokers compared with those who had never
smoked. Adults who quit smoking at age 25 to 34, 35 to 44, or 45 to 54
years gained about 10, 9, and 6 years of life, respectively, compared with
those who had continued to smoke.
Comment: The data from this report and the very similar study
involving a population of women in the United Kingdom (Pirie K et al,
The 21st century hazards of smoking and beneﬁts of stopping: a prospective
study of one million women in the UK) also featured in this Abstract
Section of the Journal have remarkably similar ﬁndings and conclusions.
These data provide quantitative information for use with our patients. In
particular, a focus on cessation of smoking and quitting smoking before
age 40 years will reduce by w90% the decade of life that is lost from
continued smoking. This is very quantitative and straightforward informa-
tion we can use in counseling our patients and their families.The 21st Century Hazards of Smoking and Beneﬁts of Stopping: A
Prospective Study of One Million Women in the UK
Pirie K, Peto R, Reeves GK, et al. Lancet 2013:381:133-41.
Conclusion: Two-thirds of all deaths of smokers in their 50s, 60s, and
70s are caused by smoking. There are substantial hazards of smoking until
age 40 years, where hazards of continuing beyond 40 years are 10 times
greater. Stopping smoking before age 40 avoids >90% of excess mortality
caused by continued smoking. Stopping before age 30 avoids >97% of
excess mortality by continued smoking.
Summary: During the ﬁrst quarter of the 20th century, many men
started smoking large numbers of cigarettes from a young age. This allowed
estimates of the full hazards of smoking in middle and older age among
men. However, few women began smoking until the second quarter of
the 20th century, and smoking problems in young women did not peak
until the 1960s (Wald N et al, UK Smoking Statistics. 2nd ed. Oxford:
Oxford University Press, 1991). Therefore previous studies of the effects
of smoking on women’s health may have considerably underestimated even-
tual risks. Only now, in the 21st century, is it possible to observe directly the
full effects of prolonged smoking and of prolonged smoking cessation on
mortality among women. This was a prospective study of 1.3 million
women in the United Kingdom recruited in 1996 to 2001 and resurveyed
through the mail w3 and 8 years later. All were followed up to January 1,
2011, through national mortality records. At entrance into the study, partic-
ipants were asked whether they were current or ex-smokers and how many
cigarettes they currently smoked. Ex-smokers at entry and at the 3-year
resurvey and who had stopped before age 55 years were categorized by
the age that they had stopped smoking. Cox regression models were then
used to obtain adjusted relative risks comparing categories of smokers or
ex-smokers with never smokers. The study excluded 100,000 women
because of previous disease, and 1.2 million women with the median birth
year of 1943 and age of 55 years were included. Overall, 6% (66,498 of
1,180,652) died. Median age of death was 65 6 6 years. At baseline 20%
(232,461) were current smokers, 28% (328,417) were ex-smokers, and
52% (619,774) were never smokers. With respect to 12-year mortality,
smokers at baseline had a mortality rate ratio of 2.76 (95% conﬁdence
